Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Cardiovascular Risks Associated with Air Travel

Primary Cardiovascular Effects

  • The American College of Chest Physicians recommends that air travel increases the risk of venous thromboembolism (VTE) through prolonged immobility, with the absolute risk of symptomatic VTE being approximately 1 in 4,600 flights lasting over 4 hours, increasing by 18% for each additional 2 hours of flight duration 1, 2
  • Prolonged air travel creates a 2.8-fold increased risk of VTE compared to non-travelers, with the association strongest for flights exceeding 8-10 hours 1
  • The risk increases through the Virchow triad mechanism: immobility-induced venous stasis, hypercoagulability, and endothelial injury 2
  • Window seating doubles the VTE risk compared to aisle seating, and increases risk sixfold in individuals with BMI >30 kg/m² 3, 4
  • Patients with chronic heart failure face a 1.57-fold higher risk of VTE compared to the general population 2, 3

Cardiac Emergencies During Flight

  • Cardiac emergencies account for 43% of all on-board medical incidents, based on analysis of approximately 20,000 in-flight medical events 3, 5
  • Common cardiac issues include circulatory collapse, hypertension, chest symptoms, and dehydration 3, 6
  • Blood pressure management is required in 76% of cardiac incidents, oxygen delivery in 48%, and automated external defibrillator use in 6% 3, 5

Risk Factors Requiring Special Attention

  • Patients with recent myocardial infarction, uncontrolled hypertension, recent cardiac surgery (CABG or PCI), or uncontrolled arrhythmias require medical clearance before flying 3, 7, 8
  • Those with heart failure with reduced ejection fraction (HFrEF) or recurrent syncope need medication optimization and symptom assessment pre-departure 3, 7
  • Uncontrolled hypertension increases risk of hypertensive crisis during flight 3, 7
  • Individual risk factors include previous VTE, recent surgery or trauma, active malignancy, pregnancy, estrogen use, advanced age, limited mobility, severe obesity, and thrombophilic disorders 1

Prevention Strategies

  • Frequent ambulation (walking cabin aisles every 2 hours minimum) and calf muscle exercises are the cornerstone of DVT prevention 1, 9, 10
  • Leg exercises improve popliteal venous flow during prolonged seated immobility 3, 4
  • Adequate hydration with 0.5-1 L additional non-alcoholic fluid intake is recommended 2, 3, 11
  • Below-knee graduated compression stockings (15-30 mmHg at ankle) should be worn during the entire flight by those with VTE risk factors 1, 3, 4, 9
  • Requesting an aisle seat facilitates movement and reduces VTE risk compared to window seating 1, 9, 10

Pharmacologic Prophylaxis

  • Aspirin is NOT recommended for VTE prevention during air travel due to insufficient evidence of benefit and meaningful bleeding risk 1, 9, 10
  • For substantially high-risk individuals, one dose of low-molecular-weight heparin (enoxaparin) may be considered, though evidence is limited 3, 4
  • The LONFLIT-3 study showed 0% asymptomatic DVT with enoxaparin versus 4.8% in controls, but this was a small study of only 300 high-risk individuals 3, 5

Special Considerations for Heart Failure Patients

  • Patients with stable heart failure can travel by air, but require careful fluid and medication management 3, 5
  • Fluid restriction of 1.5-2.0 L per day may be needed for severe heart failure, with additional 0.5-1.0 L for hot/dry destinations 3, 5
  • Patients should carry sufficient medication in carry-on luggage, medication lists, device interrogation printouts, and emergency contact information 4, 5
  • Signs of volume depletion (fatigue, postural dizziness, low urine output) require temporary reduction or discontinuation of diuretics and RAAS inhibitors 2, 8

REFERENCES